Tumor targeting with a 99mTc-labeled AS1411 aptamer in prostate tumor cells Z Noaparast, SJ Hosseinimehr, M Piramoon, SM Abedi Journal of drug targeting 23 (6), 497-505, 2015 | 39 | 2015 |
Preparation and utilization of microporous molecularly imprinted polymer for sustained release of tetracycline M Mirzaei, SAH Najafabadi, M Abdouss, S Azodi‐Deilami, E Asadi, ... Journal of applied polymer science 128 (3), 1557-1562, 2013 | 29 | 2013 |
99mTc‐anti‐epidermal growth factor receptor nanobody for tumor imaging M Piramoon, SJ Hosseinimehr, K Omidfar, Z Noaparast, SM Abedi Chemical biology & drug design 89 (4), 498-504, 2017 | 19 | 2017 |
Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy M Piramoon, F Khodadust, SJ Hosseinimehr Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (2), 188529, 2021 | 18 | 2021 |
The past, current studies and future of organometallic 99mTc (CO) 3 labeled peptides and proteins M Piramoon, S Jalal Hosseinimehr Current Pharmaceutical Design 22 (31), 4854-4867, 2016 | 14 | 2016 |
In vitro and in silico evaluation of P‐glycoprotein inhibition through 99mTc‐methoxyisobutylisonitrile uptake SS Hosseini Balef, M Piramoon, SJ Hosseinimehr, H Irannejad Chemical biology & drug design 93 (3), 283-289, 2019 | 12 | 2019 |
Solvent-free Synthesis and Antimicrobial Activity of Dihydroquinazolinone Derivatives N Keikhosravi, E Dehghan-Ghahfarokhi, S Abdollahi, M Piramoon, ... Journal of Medicinal and Chemical Sciences 5 (3), 308-314, 2022 | 5 | 2022 |
Preventive risk assessment of medication in intensive wards H Hayati, M Piramoon International Journal of Preventive Medicine 14 (1), 117, 2023 | 1 | 2023 |
Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans N Vaseghi, M Piramoon, S Khojasteh, K Abbasi, S Mohseni, J Javidnia, ... Current Medical Mycology (CMM), 0, 2022 | | 2022 |